Download PDF
Thromb Haemost 2001; 86(01): 178-188
DOI: 10.1055/s-0037-1616216
Research Article
Schattauer GmbH

The Vascular Biology of the Glycoprotein Ib-IX-V Complex

Michael C. Berndt
1   Hazel and Pip Appel Vascular Biology Laboratory, Baker Medical Research Institute, Prahran, Australia
,
Yang Shen
1   Hazel and Pip Appel Vascular Biology Laboratory, Baker Medical Research Institute, Prahran, Australia
,
Sacha M. Dopheide
2   Department of Medicine, Australian Centre for Blood Diseases, Monash Medical School, Box Hill, Victoria, Australia
,
Elizabeth E. Gardiner
1   Hazel and Pip Appel Vascular Biology Laboratory, Baker Medical Research Institute, Prahran, Australia
,
Robert K. Andrews
1   Hazel and Pip Appel Vascular Biology Laboratory, Baker Medical Research Institute, Prahran, Australia
› Author Affiliations
Further Information

Publication History

Publication Date:
12 December 2017 (online)

    Permissions and Reprints

Summary

It has long been recognized that binding of von Willebrand factor (vWf) by the platelet membrane glycoprotein (GP) Ib-IX-V complex initiates the cascade of events leading to thrombosis and haemostasis. In the last several years, however, it has become apparent that the GP Ib-IX-V complex plays a much broader role in vascular biology, a recognition in part due to the identification of novel adhesive ligands for GP Ib-IX-V such as P-selectin and Mac-1. Binding of vWf by the GP Ib-IX-V complex is also important in formation of the developing thrombus. Platelets can utilize the GP Ib-IX-V complex and PSGL-1 to roll on activated endothelium via surface-expressed endothelial P-selectin. The GP Ib-IX-V complex can bind the I domain of Mac-1, a binding interaction potentially relevant to transmigration of macrophages through mural thrombus, a process required for vessel remodeling post angioplasty. This review will focus on recent advances in our understanding of the structure and function of this important platelet receptor, with particular emphasis on insights made within the last two years.

Key words

GP Ib-IX-V complex - von Willebrand factor - thrombosis - platelet activation - signalling
 

  • References

  • 1 Moroi M, Jung SM, Shinmyozu K, Tomiyama Y, Ordinas A, Diaz-Ricart M. Analysis of platelet adhesion to a collagen-coated surface under flow conditions: the involvement of glycoprotein VI in the platelet adhesion. Blood 1996; 88: 2081-92.
    PubMedGoogle Scholar
  • 2 Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell 1998; 94: 657-66.
    CrossrefPubMedGoogle Scholar
  • 3 Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84: 289-97.
    CrossrefPubMedGoogle Scholar
  • 4 Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76: 301-14.
    CrossrefPubMedGoogle Scholar
  • 5 Fredrickson BJ, Dong JF, McIntire LV, Lopez JA. Shear-dependent rolling on von Willebrand factor of mammalian cells expressing the platelet glycoprotein Ib-IX-V complex. Blood 1998; 92: 3684-93.
    PubMedGoogle Scholar
  • 6 Cranmer SL, Ulsemer P, Cooke BM, Salem HH, de la Salle C, Lanza F, Jackson SP. Glycoprotein (GP) Ib-IX-transfected cells roll on a von Willebrand factor matrix under flow. Importance of the GPIb/actin-binding protein (ABP-280) interaction in maintaining adhesion under high shear. J Biol Chem 1999; 274: 6097-106.
    CrossrefPubMedGoogle Scholar
  • 7 Denis C, Methia N, Frenette PS, Rayburn H, Ullman-Cullere M, Hynes RO, Wagner DD. A mouse model of severe von Willebrand disease: defects in haemostasis and thrombosis. Proc Natl Acad Sci USA 1998; 95: 9524-9.
    CrossrefPubMedGoogle Scholar
  • 8 Peterson DM, Stathopoulos NA, Giorgio TD, Hellums JD, Moake JL. Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa. Blood 1987; 69: 625-8.
    PubMedGoogle Scholar
  • 9 McCrary JK, Nolasco LH, Hellums JD, Kroll MH, Turner NA, Moake JL. Direct demonstration of radiolabeled von Willebrand factor binding to platelet glycoprotein Ib and IIb-IIIa in the presence of shear stress. Ann Biomed Eng 1995; 23: 787-93.
    CrossrefPubMedGoogle Scholar
  • 10 Goto S, Salomon DR, Ikeda Y, Ruggeri ZM. Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets. J Biol Chem 1995; 270: 23352-61.
    CrossrefPubMedGoogle Scholar
  • 11 Goto S, Ikeda Y, Saldivar E, Ruggeri ZM. Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. J Clin Invest 1998; 101: 479-86.
    CrossrefPubMedGoogle Scholar
  • 12 Tsuji S, Sugimoto M, Miyata S, Kuwahara M, Kinoshita S, Yoshioka A. Real-time analysis of mural thrombus formation in various platelet aggregation disorders: distinct shear-dependent roles of platelet receptors and adhesive proteins under flow. Blood 1999; 94: 968-75.
    CrossrefPubMedGoogle Scholar
  • 13 Kulkarni S, Dopheide SM, Yap CL, Ravanat C, Freund M, Mangin P, Heel KA, Street A, Harper IS, Lanza F, Jackson SP. A revised model of platelet aggregation. J Clin Invest 2000; 105: 783-91.
    CrossrefPubMedGoogle Scholar
  • 14 Wu YP, Vink T, Schiphorst M, van Zanten GH, MJ IJ, de Groot PG, Sixma JJ. Platelet thrombus formation on collagen at high shear rates is mediated by von Willebrand factor-glycoprotein Ib interaction and inhibited by von Willebrand factor-glycoprotein IIb/IIIa interaction. Arterioscler Thromb Vasc Biol 2000; 20: 1661-7.
    CrossrefPubMedGoogle Scholar
  • 15 Frenette PS, Johnson RC, Hynes RO, Wagner DD. Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc Natl Acad Sci USA 1995; 92: 7450-4.
    CrossrefPubMedGoogle Scholar
  • 16 Frenette PS, Moyna C, Hartwell DW, Lowe JB, Hynes RO, Wagner DD. Platelet-endothelial interactions in inflamed mesenteric venules. Blood 1998; 91: 1318-24.
    PubMedGoogle Scholar
  • 17 Romo GM, Dong JF, Schade AJ, Gardiner EE, Kansas GS, Li CQ, Mc Intire LV, Berndt MC, Lopez JA. The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin. J Exp Med 1999; 190: 803-14.
    CrossrefPubMedGoogle Scholar
  • 18 Frenette PS, Denis CV, Weiss L, Jurk K, Subbarao S, Kehrel B, Hartwig JH, Vestweber D, Wagner DD. P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J Exp Med 2000; 191: 1413-22.
    CrossrefPubMedGoogle Scholar
  • 19 Kansas GS. Selectins and their ligands: current concepts and controversies. Blood 1996; 88: 3259-87.
    PubMedGoogle Scholar
  • 20 Coughlan AF, Hau H, Dunlop LC, Berndt MC, Hancock WW. P-selectin and platelet-activating factor mediate initial endotoxin-induced neutropenia. J Exp Med 1994; 179: 329-34.
    CrossrefPubMedGoogle Scholar
  • 21 Lehr HA, Olofsson AM, Carew TE, Vajkoczy P, von Andrian UH, Hubner C, Berndt MC, Steinberg D, Messmer K, Arfors KE. P-selectin mediates the interaction of circulating leukocytes with platelets and micro-vascular endothelium in response to oxidized lipoprotein in vivo. Lab Invest 1994; 71: 380-6.
    PubMedGoogle Scholar
  • 22 Katayama T, Ikeda Y, Handa M, Tamatani T, Sakamoto S, Ito M, Ishimura Y, Suematsu M. Immunoneutralization of glycoprotein Ibalpha attenuates endotoxin- induced interactions of platelets and leukocytes with rat venular endothelium in vivo. Circ Res 2000; 86: 1031-7.
    CrossrefPubMedGoogle Scholar
  • 23 Andre P, Denis CV, Ware J, Saffaripour S, Hynes RO, Ruggeri ZM, Wagner DD. Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins. Blood 2000; 96: 3322-8.
    PubMedGoogle Scholar
  • 24 Bombeli T, Schwartz BR, Harlan JM. Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. J Exp Med 1998; 187: 329-39.
    CrossrefPubMedGoogle Scholar
  • 25 D’Souza SE, Byers-Ward VJ, Gardiner EE, Wang H, Sung SS. Identification of an active sequence within the first immunoglobulin domain of intercellular cell adhesion molecule-1 (ICAM-1) that interacts with fibrinogen. J Biol Chem 1996; 271: 24270-7.
    CrossrefPubMedGoogle Scholar
  • 26 Gardiner EE, D’Souza SE. A mitogenic action for fibrinogen mediated through intercellular adhesion molecule-1. J Biol Chem 1997; 272: 15474-80.
    CrossrefPubMedGoogle Scholar
  • 27 Subramaniam M, Frenette PS, Saffaripour S, Johnson RC, Hynes RO, Wagner DD. Defects in haemostasis in P-selectin-deficient mice. Blood 1996; 87: 1238-42.
    PubMedGoogle Scholar
  • 28 Lopez JA, Andrews RK, Afshar-Kharghan V, Berndt MC. Bernard-Soulier syndrome. Blood 1998; 91: 4397-418.
    PubMedGoogle Scholar
  • 29 Beguin S, Kumar R, Keularts I, Seligsohn U, Coller BS, Hemker HC. Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor. Blood 1999; 93: 564-70.
    PubMedGoogle Scholar
  • 30 Andrews RK, Lopez JA, Berndt MC. Molecular mechanisms of platelet adhesion and activation. Int J Biochem Cell Biol 1997; 29: 91-105.
    CrossrefPubMedGoogle Scholar
  • 31 Lopez JA, Dong JF. Structure and function of the glycoprotein Ib-IX-V complex. Curr Opin Hematol 1997; 4: 323-9.
    CrossrefPubMedGoogle Scholar
  • 32 Wicki AN, Clemetson KJ. The glycoprotein Ib complex of human blood platelets. Eur J Biochem 1987; 163: 43-50.
    CrossrefPubMedGoogle Scholar
  • 33 Berndt MC, Gregory C, Kabral A, Zola H, Fournier D, Castaldi PA. Purification and preliminary characterization of the glycoprotein Ib complex in the human platelet membrane. Eur J Biochem 1985; 151: 637-49.
    CrossrefPubMedGoogle Scholar
  • 34 Du X, Beutler L, Ruan C, Castaldi PA, Berndt MC. Glycoprotein Ib and glycoprotein IX are fully complexed in the intact platelet membrane. Blood 1987; 69: 1524-7.
    PubMedGoogle Scholar
  • 35 Modderman PW, Admiraal LG, Sonnenberg A, von dem Borne AE. Glycoproteins V and Ib-IX form a noncovalent complex in the platelet membrane. J Biol Chem 1992; 267: 364-9.
    PubMedGoogle Scholar
  • 36 Lopez JA, Chung DW, Fujikawa K, Hagen FS, Papayannopoulou T, Roth GJ. Cloning of the alpha chain of human platelet glycoprotein Ib: a trans-membrane protein with homology to leucine-rich alpha 2-glycoprotein. Proc Natl Acad Sci USA 1987; 84: 5615-9.
    CrossrefPubMedGoogle Scholar
  • 37 Fox JE, Aggerbeck LP, Berndt MC. Structure of the glycoprotein Ib. IX complex from platelet membranes. J Biol Chem 1988; 263: 4882-90.
    PubMedGoogle Scholar
  • 38 Titani K, Takio K, Handa M, Ruggeri ZM. Amino acid sequence of the von Willebrand factor-binding domain of platelet membrane glycoprotein Ib. Proc Natl Acad Sci USA 1987; 84: 5610-4.
    CrossrefPubMedGoogle Scholar
  • 39 Okumura I, Lombart C, Jamieson GA. Platelet glycocalicin. II. Purification and characterization. J Biol Chem 1976; 251: 5950-5.
    PubMedGoogle Scholar
  • 40 Lopez JA, Ludwig EH, McCarthy BJ. Polymorphism of human glycoprotein Ib alpha results from a variable number of tandem repeats of a 13-amino acid sequence in the mucin-like macroglycopeptide region. Structure/ function implications. J Biol Chem 1992; 267: 10055-61.
    PubMedGoogle Scholar
  • 41 Ishida F, Furihata K, Ishida K, Yan J, Kitano K, Kiyosawa K, Furuta S. The largest variant of platelet glycoprotein Ib alpha has four tandem repeats of 13 amino acids in the macroglycopeptide region and a genetic linkage with methionine145. Blood 1995; 86: 1357-60.
    PubMedGoogle Scholar
  • 42 Dong JF, Li CQ, Lopez JA. Tyrosine sulfation of the glycoprotein Ib-IX complex: identification of sulfated residues and effect on ligand binding. Biochemistry 1994; 33: 13946-53.
    CrossrefPubMedGoogle Scholar
  • 43 Ward CM, Andrews RK, Smith AI, Berndt MC. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin. Biochemistry 1996; 35: 4929-38.
    CrossrefPubMedGoogle Scholar
  • 44 Marchese P, Murata M, Mazzucato M, Pradella P, De Marco L, Ware J, Ruggeri ZM. Identification of three tyrosine residues of glycoprotein Ib alpha with distinct roles in von Willebrand factor and alpha-thrombin binding. J Biol Chem 1995; 270: 9571-8.
    CrossrefPubMedGoogle Scholar
  • 45 Andrews RK, Fox JE. Identification of a region in the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX complex that binds to purified actin-binding protein. J Biol Chem 1992; 267: 18605-11.
    PubMedGoogle Scholar
  • 46 Du X, Fox JE, Pei S. Identification of a binding sequence for the 14-3-3 protein within the cytoplasmic domain of the adhesion receptor, platelet glycoprotein Ib alpha. J Biol Chem 1996; 271: 7362-7.
    CrossrefPubMedGoogle Scholar
  • 47 Andrews RK, Harris SJ, McNally T, Berndt MC. Binding of purified 14-3-3 zeta signaling protein to discrete amino acid sequences within the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX-V complex. Biochemistry 1998; 37: 638-47.
    CrossrefPubMedGoogle Scholar
  • 48 Lopez JA, Chung DW, Fujikawa K, Hagen FS, Davie EW, Roth GJ. The alpha and beta chains of human platelet glycoprotein Ib are both trans-membrane proteins containing a leucine-rich amino acid sequence. Proc Natl Acad Sci USA 1988; 85: 2135-9.
    CrossrefPubMedGoogle Scholar
  • 49 Hickey MJ, Williams SA, Roth GJ. Human platelet glycoprotein IX: an adhesive prototype of leucine-rich glycoproteins with flank-center-flank structures. Proc Natl Acad Sci USA 1989; 86: 6773-7.
    CrossrefPubMedGoogle Scholar
  • 50 Wardell MR, Reynolds CC, Berndt MC, Wallace RW, Fox JE. Platelet glycoprotein Ib beta is phosphorylated on serine 166 by cyclic AMP-dependent protein kinase. J Biol Chem 1989; 264: 15656-61.
    PubMedGoogle Scholar
  • 51 Fox JE, Berndt MC. Cyclic AMP-dependent phosphorylation of glyco-protein Ib inhibits collagen-induced polymerization of actin in platelets. J Biol Chem 1989; 264: 9520-6.
    PubMedGoogle Scholar
  • 52 Calverley DC, Kavanagh TJ, Roth GJ. Human signaling protein 14-3-3 zeta interacts with platelet glycoprotein Ib subunits Ibalpha and Ibbeta. Blood 1998; 91: 1295-303.
    PubMedGoogle Scholar
  • 53 Feng S, Christodoulides N, Resendiz JC, Berndt MC, Kroll MH. Cytoplasmic domains of GpIbalpha and GpIbbeta regulate 14-3-3zeta binding to GpIb/IX/V. Blood 2000; 95: 551-7.
    PubMedGoogle Scholar
  • 54 Hickey MJ, Hagen FS, Yagi M, Roth GJ. Human platelet glycoprotein V: characterization of the polypeptide and the related Ib-V-IX receptor system of adhesive, leucine-rich glycoproteins. Proc Natl Acad Sci USA 1993; 90: 8327-31.
    CrossrefPubMedGoogle Scholar
  • 55 Calverley DC, Yagi M, Stray SM, Roth GJ. Human platelet glycoprotein V: its role in enhancing expression of the glycoprotein Ib receptor. Blood 1995; 86: 1361-7.
    PubMedGoogle Scholar
  • 56 Ruggeri ZM. Structure and function of von Willebrand factor. Thromb Haemost 1999; 82: 576-84.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 57 Miyata S, Goto S, Federici AB, Ware J, Ruggeri ZM. Conformational changes in the A1 domain of von Willebrand factor modulating the interaction with platelet glycoprotein Ibalpha. J Biol Chem 1996; 271: 9046-53.
    CrossrefPubMedGoogle Scholar
  • 58 Siedlecki CA, Lestini BJ, Kottke-Marchant KK, Eppell SJ, Wilson DL, Marchant RE. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. Blood 1996; 88: 2939-50.
    CrossrefPubMedGoogle Scholar
  • 59 Berndt MC, Ward CM, Booth WJ, Castaldi PA, Mazurov AV, Andrews RK. Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin. Biochemistry 1992; 31: 11144-51.
    CrossrefPubMedGoogle Scholar
  • 60 Girma JP, Takahashi Y, Yoshioka A, Diaz J, Meyer D. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib. Thromb Haemost 1990; 64: 326-32.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 61 Azuma H, Sugimoto M, Ruggeri ZM, Ware J. A role for von Willebrand factor proline residues 702-704 in ristocetin-mediated binding to platelet glycoprotein Ib. Thromb Haemost 1993; 69: 192-6.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 62 De Luca M, Facey DA, Favaloro EJ, Hertzberg MS, Whisstock JC, McNally T, Andrews RK, Berndt MC. Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation. Blood 2000; 95: 164-72.
    CrossrefPubMedGoogle Scholar
  • 63 Sugimoto M, Mohri H, McClintock RA, Ruggeri ZM. Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin. A model for the regulation of von Willebrand factor binding to platelet glycoprotein Ib. J Biol Chem 1991; 266: 18172-8.
    PubMedGoogle Scholar
  • 64 Shen Y, Romo GM, Dong JF, Schade A, McIntire LV, Kenny D, Whis-stock JC, Berndt MC, Lopez JA, Andrews RK. Requirement of leucine-rich repeats of glycoprotein (GP) Ibalpha for shear-dependent and static binding of von Willebrand factor to the platelet membrane GP Ib-IX-V complex. Blood 2000; 95: 903-10.
    PubMedGoogle Scholar
  • 65 Nishio K, Fujimura Y, Nishida S, Takeda I, Yoshioka A, Fukui H, Tomiyama Y, Kurata Y. Antiplatelet glycoprotein Ib monoclonal antibody (OP-F1) totally abolishes ristocetin-induced von Willebrand factor binding, but has minimal effect on the botrocetin-induced binding. Haemostasis 1991; 21: 353-9.
    PubMedGoogle Scholar
  • 66 Dong JF, Berndt MC, Schade A, McIntire LV, Andrews RK, Lopez JA. Ristocetin-dependent, but not botrocetin-dependent, binding of von Wille-brand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions. Blood 2001; 97: 162-8.
    CrossrefPubMedGoogle Scholar
  • 67 Cauwenberghs N, Ajzenberg N, Vauterin S, Hoylaerts MF, Declerck PJ, Baruch D, Deckmyn H. Characterization of murine anti-glycoprotein Ib monoclonal antibodies that differentiate between shear-induced and Ristocetin/Botrocetin-induced glycoprotein Ib-von Willebrand factor interaction. Haemostasis 2000; 30: 139-48.
    PubMedGoogle Scholar
  • 68 Dong JF, Hyun W, Lopez JA. Aggregation of mammalian cells expressing the platelet glycoprotein (GP) Ib-IX complex and the requirement for tyrosine sulfation of GP Ib alpha. Blood 1995; 86: 4175-83.
    PubMedGoogle Scholar
  • 69 Murata M, Ware J, Ruggeri ZM. Site-directed mutagenesis of a soluble recombinant fragment of platelet glycoprotein Ib alpha demonstrating negatively charged residues involved in von Willebrand factor binding. J Biol Chem 1991; 266: 15474-80.
    PubMedGoogle Scholar
  • 70 Andrews RK, Shen Y, Gardiner EE, Dong JF, Lopez JA, Berndt MC. The glycoprotein Ib-IX-V complex in platelet adhesion and signaling. Thromb Haemost 1999; 82: 357-64.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 71 Dong J, Schade AJ, Romo GM, Andrews RK, Gao S, McIntire LV, Lopez JA. Novel gain-of-function mutations of platelet glycoprotein Ibalpha by valine mutagenesis in the Cys209-Cys248 disulphide loop. Functional analysis under statis and dynamic conditions. J Biol Chem 2000; 275: 27663-70.
    PubMedGoogle Scholar
  • 72 Marchese P, Saldivar E, Ware J, Ruggeri ZM. Adhesive properties of the isolated amino-terminal domain of platelet glycoprotein Ibalpha in a flow field. Proc Natl Acad Sci USA 1999; 96: 7837-42.
    CrossrefPubMedGoogle Scholar
  • 73 Afshar-Kharghan V, Gineys G, Schade AJ, Sun L, Li CQ, McIntire LV, Dong JF, Lopez JA. Necessity of conserved asparagine residues in the leucine-rich repeats of platelet glycoprotein Ib alpha for the proper conformation and function of the ligand-binding region. Biochemistry 2000; 39: 3384-91.
    CrossrefPubMedGoogle Scholar
  • 74 Simon DI, Chen Z, Xu H, Li CQ, Dong J, McIntire LV, Ballantyne CM, Zhang L, Furman MI, Berndt MC, Lopez JA. Platelet glycoprotein Ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med 2000; 192: 193-204.
    CrossrefPubMedGoogle Scholar
  • 75 De Luca M, Dunlop LC, Andrews RK, Flannery Jr JV, Ettling R, Cumming DA, Veldman GM, Berndt MC. A novel cobra venom metalloproteinase, mocarhagin, cleaves a 10-amino acid peptide from the mature N terminus of P-selectin glycoprotein ligand receptor, PSGL-1, and abolishes P-selectin binding. J Biol Chem 1995; 270: 26734-7.
    CrossrefPubMedGoogle Scholar
  • 76 De Candia E, De Cristofaro R, Landolfi R. Thrombin-induced platelet activation is inhibited by high- and low-molecular-weight heparin. Circulation 1999; 99: 3308-14.
    CrossrefPubMedGoogle Scholar
  • 77 Yamamoto N, Kitagawa H, Tanoue K, Yamazaki H. Monoclonal antibody to glycoprotein Ib inhibits both thrombin- and ristocetin-induced platelet aggregations. Thromb Res 1985; 39: 751-9.
    CrossrefPubMedGoogle Scholar
  • 78 Lopez JA. The platelet glycoprotein Ib-IX complex. Blood Coagul Fibrinolysis 1994; 5: 97-119.
    CrossrefPubMedGoogle Scholar
  • 79 Greco NJ, Tandon NN, Jones GD, Kornhauser R, Jackson B, Yamamoto N, Tanoue K, Jamieson GA. Contributions of glycoprotein Ib and the seven transmembrane domain receptor to increases in platelet cytoplasmic [Ca2+] induced by alpha-thrombin. Biochemistry 1996; 35: 906-14.
    CrossrefPubMedGoogle Scholar
  • 80 De Cristofaro R, De Candia E, Rutella S, Weitz JI. The Asp(272)-Glu(282) region of platelet glycoprotein Ibalpha interacts with the heparin-binding site of alpha-thrombin and protects the enzyme from the heparin-catalyzed inhibition by antithrombin III. J Biol Chem 2000; 275: 3887-95.
    CrossrefPubMedGoogle Scholar
  • 81 Gralnick HR, Williams S, McKeown LP, Hansmann K, Fenton 2nd JW, Krutzsch H. High-affinity alpha-thrombin binding to platelet glycoprotein Ib alpha: identification of two binding domains. Proc Natl Acad Sci USA 1994; 91: 6334-8.
    CrossrefPubMedGoogle Scholar
  • 82 De Marco L, Mazzucato M, Masotti A, Ruggeri ZM. Localization and characterization of an alpha-thrombin-binding site on platelet glycoprotein Ib alpha. J Biol Chem 1994; 269: 6478-84.
    PubMedGoogle Scholar
  • 83 Mazzucato M, Marco LD, Masotti A, Pradella P, Bahou WF, Ruggeri ZM. Characterization of the initial alpha-thrombin interaction with glycoprotein Ib alpha in relation to platelet activation. J Biol Chem 1998; 273: 1880-7.
    CrossrefPubMedGoogle Scholar
  • 84 Katagiri Y, Hayashi Y, Yamamoto K, Tanoue K, Kosaki G, Yamazaki H. Localization of von Willebrand factor and thrombin-interactive domains on human platelet glycoprotein Ib. Thromb Haemost 1990; 63: 122-6.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 85 McKeown LP, Williams SB, Hansmann KE, Krutzsch H, Gralnick HR. Glycoprotein Ib alpha peptides inhibit thrombin and SFLLRN-induced platelet aggregation. J Lab Clin Med 1996; 128: 492-5.
    CrossrefPubMedGoogle Scholar
  • 86 Berndt MC, Phillips DR. Interaction of thrombin with platelets: purification of the thrombin substrate. Ann N Y Acad Sci 1981; 370: 87-95.
    CrossrefPubMedGoogle Scholar
  • 87 De Candia E, Hall SW, Rutella S, Landolfi R, Andrews RK, De Cristofaro R. Binding of thrombin to the Glycoprotein Ib accelerates the hydro-lysis of PAR-1 on intact platelets. J Biol Chem 2001; 276: 4692-8.
    CrossrefPubMedGoogle Scholar
  • 88 Ramakrishnan V, DeGuzman F, Bao M, Hall S, Leung L, Phillips D. A thrombin receptor function for platelet glycoprotein Ib-IX unmasked by cleavage of glycoprotein. V Proc Natl Acad Sci USA 2001; 98: 1823-8.
    PubMedGoogle Scholar
  • 89 Dong JF, Sae-Tung G, Lopez JA. Role of glycoprotein V in the formation of the platelet high-affinity thrombin-binding site. Blood 1997; 89: 4355-63.
    PubMedGoogle Scholar
  • 90 Dormann D, Clemetson KJ, Kehrel BE. The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity. Blood 2000; 96: 2469-78.
    PubMedGoogle Scholar
  • 91 Li CQ, Vindigni A, Sadler JE, Wardell MR. Platelet glycoprotein Ib-alpha binds to thrombin anion-binding exosite II inducing allosteric changes in thrombin‘s activity. J Biol Chem 2001; 276: 6161-8.
    CrossrefPubMedGoogle Scholar
  • 92 Bradford HN, Pixley RA, Colman RW. Human factor XII binding to the glycoprotein Ib-IX-V complex inhibits thrombin-induced platelet aggregation. J Biol Chem 2000; 275: 22756-63.
    CrossrefPubMedGoogle Scholar
  • 93 Bradford HN, Dela Cadena RA, Kunapuli SP, Dong JF, Lopez JA, Colman RW. Human kininogens regulate thrombin binding to platelets through the glycoprotein Ib-IX-V complex. Blood 1997; 90: 1508-15.
    PubMedGoogle Scholar
  • 94 Joseph K, Nakazawa Y, Bahou WF, Ghebrehiwet B, Kaplan AP. Platelet glycoprotein Ib: a zinc-dependent binding protein for the heavy chain of high-molecular-weight kininogen. Mol Med 1999; 5: 555-63.
    PubMedGoogle Scholar
  • 95 Andrews RK, Berndt MC. Snake venom modulators of platelet adhesion receptors and their ligands. Toxicon 2000; 38: 775-91.
    CrossrefPubMedGoogle Scholar
  • 96 Matsui T, Fujimura Y, Titani K. Snake venom proteases affecting haemostasis and thrombosis. Biochim Biophys Acta 2000; 1477: 146-56.
    CrossrefPubMedGoogle Scholar
  • 97 Fujimura Y, Kawasaki T, Titani K. Snake venom proteins modulating the interaction between von Willebrand factor and platelet glycoprotein Ib. Thromb Haemost 1996; 76: 633-9.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 98 Kini RM. Are C-type lectin-related proteins derived by proteolysis of metalloproteinase/disintegrin precursor proteins?. Toxicon 1996; 34: 1287-94.
    CrossrefPubMedGoogle Scholar
  • 99 Andrews RK, Kroll MH, Ward CM, Rose JW, Scarborough RM, Smith AI, Lopez JA, Berndt MC. Binding of a novel 50-kilodalton alboaggregin from Trimeresurus albolabris and related viper venom proteins to the platelet membrane glycoprotein Ib-IX-V complex. Effect on platelet aggregation and glycoprotein Ib-mediated platelet activation. Biochemistry 1996; 35: 12629-39.
    CrossrefPubMedGoogle Scholar
  • 100 Kowalska MA, Tan L, Holt JC, Peng M, Karczewski J, Calvete JJ, Niewiarowski S. Alboaggregins A and B. Structure and interaction with human platelets. Thromb Haemost 1998; 79: 609-13.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 101 Falati S, Edmead CE, Poole AW. Glycoprotein Ib-V-IX, a receptor for von Willebrand factor, couples physically and functionally to the Fc receptor gamma-chain, Fyn, and Lyn to activate human platelets. Blood 1999; 94: 1648-56.
    PubMedGoogle Scholar
  • 102 Hamako J, Matsui T, Nishida S, Nomura S, Fujimura Y, Ito M, Ozeki Y, Titani K. Purification and characterization of kaouthiagin, a von Wille-brand factor-binding and -cleaving metalloproteinase from Naha kaouthia cobra venom. Thromb Haemost 1998; 80: 499-505.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 103 Kroll MH, Hellums JD, McIntire LV, Schafer AI, Moake JL. Platelets and shear stress [see comments]. Blood 1996; 88: 1525-41.
    PubMedGoogle Scholar
  • 104 Du X, Ginsberg MH. Integrin alpha IIb beta 3 and platelet function. Thromb Haemost 1997; 78: 96-100.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 105 Kroll MH, Harris TS, Moake JL, Handin RI, Schafer AI. Von Willebrand factor binding to platelet GPIb initiates signals for platelet activation. J Clin Invest 1991; 88: 1568-73.
    CrossrefPubMedGoogle Scholar
  • 106 Ikeda Y, Handa M, Kamata T, Kawano K, Kawai Y, Watanabe K, Kawakami K, Sakai K, Fukuyama M, Itagaki I. et al. Transmembrane calcium influx associated with von Willebrand factor binding to GP Ib in the initiation of shear-induced platelet aggregation. Thromb Haemost 1993; 69: 496-502.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 107 Jackson SP, Schoenwaelder SM, Yuan Y, Rabinowitz I, Salem HH, Mitchell CA. Adhesion receptor activation of phosphatidylinositol 3-kinase. von Willebrand factor stimulates the cytoskeletal association and activation of phosphatidylinositol 3-kinase and pp60c-src in human platelets. J Biol Chem 1994; 269: 27093-9.
    PubMedGoogle Scholar
  • 108 Razdan K, Hellums JD, Kroll MH. Shear-stress-induced von Willebrand factor binding to platelets causes the activation of tyrosine kinase(s). Biochem J 1994; 302: 681-6.
    CrossrefPubMedGoogle Scholar
  • 109 Andrews RK, Gorman JJ, Booth WJ, Corino GL, Castaldi PA, Berndt MC. Cross-linking of a monomeric 39/34-kDa dispase fragment of von Willebrand factor (Leu-480/Val-481-Gly-718) to the N-terminal region of the alpha-chain of membrane glycoprotein Ib on intact platelets with bis(sulfosuccinimidyl) suberate. Biochemistry 1989; 28: 8326-36.
    CrossrefPubMedGoogle Scholar
  • 110 Schulte am Esch 2nd J, Cruz MA, Siegel JB, Anrather J, Robson SC. Activation of human platelets by the membrane-expressed A1 domain of von Willebrand factor. Blood 1997; 90: 4425-37.
    PubMedGoogle Scholar
  • 111 Torti M, Bertoni A, Canobbio I, Sinigaglia F, Lapetina EG, Balduini C. Rap1B and Rap2B translocation to the cytoskeleton by von Willebrand factor involves FcgammaII receptor-mediated protein tyrosine phosphorylation. J Biol Chem 1999; 274: 13690-7.
    CrossrefPubMedGoogle Scholar
  • 112 Sullam PM, Hyun WC, Szollosi J, Dong J, Foss WM, Lopez JA. Physical proximity and functional interplay of the glycoprotein Ib-IX-V complex and the Fc receptor FcgammaRIIA on the platelet plasma membrane. J Biol Chem 1998; 273: 5331-6.
    CrossrefPubMedGoogle Scholar
  • 113 Watson SP. Collagen receptor signaling in platelets and megakaryocytes. Thromb Haemost 1999; 82: 365-76.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 114 Tsuji M, Ezumi Y, Arai M, Takayama H. A novel association of Fc receptor gamma-chain with glycoprotein VI and their co-expression as a collagen receptor in human platelets. J Biol Chem 1997; 272: 23528-31.
    CrossrefPubMedGoogle Scholar
  • 115 Gu M, Xi X, Englund GD, Berndt MC, Du X. Analysis of the roles of 14-3-3 in the platelet glycoprotein Ib-IX- mediated activation of integrin alpha(IIb)beta(3) using a reconstituted mammalian cell expression model. J Cell Biol 1999; 147: 1085-96.
    CrossrefPubMedGoogle Scholar
  • 116 Du X, Harris SJ, Tetaz TJ, Ginsberg MH, Berndt MC. Association of a phospholipase A2 (14-3-3 protein) with the platelet glycoprotein Ib-IX complex. J Biol Chem 1994; 269: 18287-90.
    PubMedGoogle Scholar
  • 117 Bodnar RJ, Gu M, Li Z, Englund GD, Du X. The cytoplasmic domain of the platelet glycoprotein Ibalpha is phosphorylated at serine 609. J Biol Chem 1999; 274: 33474-9.
    CrossrefPubMedGoogle Scholar
  • 118 Munday AD, Berndt MC, Mitchell CA. Phosphoinositide 3-kinase forms a complex with platelet membrane glycoprotein Ib-IX-V complex and 14-3-3zeta. Blood 2000; 96: 577-84.
    PubMedGoogle Scholar
  • 119 Cunningham JG, Meyer SC, Fox JE. The cytoplasmic domain of the alpha-subunit of glycoprotein (GP) Ib mediates attachment of the entire GP Ib-IX complex to the cytoskeleton and regulates von Willebrand factor-induced changes in cell morphology. J Biol Chem 1996; 271: 11581-7.
    CrossrefPubMedGoogle Scholar
  • 120 Kovacsovics TJ, Hartwig JH. Thrombin-induced GPIb-IX centralization on the platelet surface requires actin assembly and myosin II activation. Blood 1996; 87: 618-29.
    PubMedGoogle Scholar
  • 121 Fox J, Meyer S. The platelet cytoskeleton. In: Berndt M. ed. Platelets, Thrombosis and the Vessel Wall. Amsterdam: Harwood Academic Publishers; 2000: 103-26.
    Google Scholar
  • 122 Yuan Y, Kulkarni S, Ulsemer P, Cranmer SL, Yap CL, Nesbitt WS, Harper I, Mistry N, Dopheide SM, Hughan SC, Williamson D, de la Salle C, Salem HH, Lanza F, Jackson SP. The von Willebrand factor-glycoprotein Ib/V/IX interaction induces actin polymerization and cytoskeletal reorganization in rolling platelets and glycoprotein Ib/V/IX-transfected cells. J Biol Chem 1999; 274: 36241-51.
    CrossrefPubMedGoogle Scholar
  • 123 Mistry N, Cranmer SL, Yuan Y, Mangin P, Dopheide SM, Harper I, Giuliano S, Dunstan DE, Lanza F, Salem HH, Jackson SP. Cytoskeletal regulation of the platelet glycoprotein Ib/V/IX-von Willebrand factor interaction. Blood 2000; 96: 3480-9.
    PubMedGoogle Scholar